Glimestar-MV 2 Tablet ER
Marketer
Mankind Pharma Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimestar-MV 2 Tablet ER
Diabetam-Duo ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetam-Duo ER with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counter this. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Diabetam-Duo ER is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should consult their physician before use. Pregnant or breastfeeding individuals should seek medical advice prior to commencing treatment. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are necessary.
Primary Ingredients of Glimestar-MV 2 Tablet ER
There is no text provided to rephrase.
Uses of Glimestar-MV 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimestar-MV 2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Glimestar-MV 2 Tablet ER on an empty stomach.
Common Side effects of Glimestar-MV 2 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimestar-MV 2 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length of this medication. Ingest the Glimestar-MV 2 Tablet ER whole; do not break, crush, or chew it. Administer on an empty stomach.
How Glimestar-MV 2 Tablet ER works:
Glimestar-MV 2 Extended-Release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimestar-MV 2 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimestar-MV 2 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimestar-MV 2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Extended-release Glimestar-MV 2 tablets are likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, their use is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Glimestar-MV 2 Tablet ER to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Initiate Glimestar-MV 2 Tablet ER therapy at a reduced dosage for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe liver disease.
What if you forget to take Glimestar-MV 2 Tablet ER :
Should you forget a Glimestar-MV 2 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimestar-MV 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |





